Although mouse strains like TASD or J20, combining multiple APP mutations, demonstrate more aggressive AD‐like pathology, these models still reflect primarily amyloid pathology rather than the full spectrum of AD (also including tauopathy, neuroinflammation, and synaptic dysfunction).82, 83. The gene discussed is APP; the disease is amyloidosis.